Lapses at the New England Journal of Medicine

Bombardier C. , Laine L. , Reicin A. . Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520–8

Lexchin J. , Light D.W. Commercial influence and the content of medical journals. BMJ 2006; 332: 1444–7 [doi: 10.1136/bmj.332.7555.1444]

Horton R. The dawn of McScience. NY Rev Books 2004; 51: 7–9

Armstrong D. Bitter pill: how the New England Journal missed warning signs on Vioxx. Wall Street Journal 2006 May 15: A1

Altman L.K. For science's gatekeepers: a credibility gap. New York Times 2006 May 2

Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005; 2: e138

James H. The Bostonians. Harmondsworth: Penguin, 2000

Angell M. The Truth About Drug Companies: How They Deceive Us and What To Do About It. New York: Random House, 2005

Kassirer J.P. On The Take: How Medicine's Complicity With Big Business Can Endanger Your Health. New York: Oxford University Press, 2004

Gottlieb S. FDA censures NEJM editor. BMJ 2000; 320: 1562

Curfman G.D. , Morrissey S. , Drazen J.M. Expression of concern: Bombardier, et al., ‘Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis’. N Engl J Med 2000; 343: 1520–8. N Engl J Med 2005; 353: 2813–14

Curfman G.D. , Morrissey S. , Drazen J.M. Expression of concern reaffirmed. N Engl J Med 2006; 354: 1193 [http://www.nejm.org]

Mukherjee D. , Nissen S.E. , Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286: 954–9

FitzGerald G.A. , Patrono C. Drug therapy: the coxibs, selective inhibitors of cycooxygenase-2. New Engl J Med 2001; 345: 433–42

Anonymous. Correction. N Engl J Med 2006; 355: ?pages? [http://content.nejm.org/cgi/content/short/NEJMx060029]

Bresalier R.S. , Sandler R.S. , Quan H. . Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092–102

Smith R. Peer review: a flawed process at the heart of science and journals. J R Soc Med 2006; 99: 178–82

Smith R. , Roberts I. Patient safety requires a new way to publish clinical trials. PLoS Clin Trials 2006; 1: e6 [DOI: 10.1371/journal.pctr.0010006]